31Dec 2016

ASSESSMENT OF MULTIPLE SCLEROSIS AWARENESS: KNOWLEDGE AND ATTITUDE AMONG SAUDI POPULATION IN TAIF CITY, KSA.

  • Anatomy & histology department college of Medicine, Taif University, KSA.
  • Histology & Cell Biology department, Faculty of Medicine, Zagazig University, Egypt.
  • Medical Intern, College of Medicine, Taif University, KSA.
Crossref Cited-by Linking logo
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Multiple sclerosis (MS) is an organ specific inflammatory disease that considered the main cause of chronic neurologic disability in young and middle-aged adults with increased prevalence in Saudi Arabia. Public awareness MS is generally poor, and this limited understanding delays the early diagnosis and treatment of patients. This study was community based cross sectional study that conducted in different public areas. A structured questionnaire including questions on knowledge and attitude of MS was administered. A total of 900 questionnaires were distributed and 715 were completed the questionnaire. The mean knowledge score among the study cohort was 8.74?±?2.7 and the mean attitude score was 2.19± 1.8 with no significant variation regarding age and sex of participants. Learning from surrounding people was the only source of information with significantly high knowledge and attitude score. Also, participants who recorded knowing someone with MS was significantly had higher knowledge and attitude scores. Most respondents in our sample suffered from deficiency of background information about MS and health education. Therefore, more intensified awareness programs among population are necessary to ensure reliable information reach the public in order for early detection and management of this serious disease. Also, further researches are needed to identify causes of inadequate knowledge and attitude of MS among Saudi population. More utilization of Media as an important source of MS is important to improve awareness among the community.

  1. Multiple Sclerosis International Federation, “Atlas of MS,” 2013, http://www.msif.org/en/about msif/what we do/atlas of Ms.
  2. Bohlega S, Inshasi J, Al Tahan A,et al. Multiple sclerosis in the Arabian Gulf countries: a consensus statement. J Neurol. 2013; 260:2959–2963.
  3. Al Rajeh S, Bademosi O, Ismail H, et al. A community survey of neurological disorders in Saudi Arabia: The Thugbah study. Neuroepidemiology 1993;12:164–178
  4. Mansouri B, Asadollahi S, Heidari K et al. Risk factors for increased multiple sclerosis susceptibility in the Iranian population. J Clin Neurosci.2014; S0967-5868(14)00311-7.
  5. Kampman MT, Steffensen LH, Mellgren SI, Jørgensen L. Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial. Mult Scler. 2012; 18(8):1144-51.
  6. Derakhshandi H, Etemadifar M, Feizi A, et al. Preventive effect of vitamin D3 supplementation on conversion of optic neuritis to clinically definite multiple sclerosis: a double blind, randomized, placebo-controlled pilot clinical trial. Acta Neurol Belg. 2012;113(3):257-63.
  7. Hedström AK, Bomfim IL, Barcellos L et al. Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis. Journal of Neurology. 2014; 82:1–8.
  8. . Goldenberg Multiple Sclerosis Review. P T. Mar 2012; 37(3): 175–184.
  9. Alroughani A, Alsharoqi, S et al. Future of Management of Multiple Sclerosis in the Middle East: A Consensus View from Specialists in Ten Countries. Mult Scler Int.2013; 2013:952321.
  10. Gold R, Wolinsky JS, Amato MP, Comi G. Evolving expectations around early management of multiple sclerosis. Ther Adv Neurol Disord. 2010 Nov;3(6):351-67.
  11. Al Tahan AM, Alsharoqi I, Bohlega SA, Dahdaleh M, Daif A, et al. Characteristics of multiple sclerosis in the Middle East with special reference to the applicability of international guidelines to the region. Int J Neurosci. 2014 Sep;124(9):635-41.
  12. Miller J R. The Importance of Early Diagnosis of Multiple Sclerosis. J Manag Care Pharm. 2004;10(3)(suppl S-b):S4-S11.
  13. Yamout B, Dahdaleh M, Al Jumah MA, Al-Shammri S, Al Sharoqi I, Al-Tahan AR, Bohlega S, Deleu D, Inshasi J, Khalifa A, Szólics M. Adherence to disease-modifying drugs in patients with multiple sclerosis: a consensus statement from the Middle East MS Advisory Group. Int J Neurosci. 2010 Apr;120(4):273-9.
  14. Rolak LA.. Multiple Sclerosis: It's Not The Disease You Thought It Was Clin Med Res. 2003 Jan; 1(1): 57–60.
  15. Lolli F, Rovero P, Chelli M, Papini AM Toward biomarkers in multiple sclerosis: new advances. Expert Rev Neurother. 2006 May; 6(5):781-94.
  16. Burks J S., Bigley G K, and  Hill H H. Rehabilitation challenges in multiple sclerosis. Ann Indian Acad Neurol. 2009 Oct-Dec; 12(4): 296–306.
  17. Hudaif H.S.A., Bwardi N.A. Bwardi S. Kojan. Assessment of multiple sclerosis awareness and knowledge among the Saudi population in Riyadh City. Multiple sclerosis and related disorders. November 2014Volume 3, Issue 6, Page 758
  18. Arhan E, Serdaroglu A, Soysal S, Ozcelik A, Gucuyener K, Demir E. Assessment of mothers' knowledge and perceptions of electroencephalography and determination of the short-term effect of an informational leaflet. Epilepsy and Behavior. 2009;15(4):491–495.
  19. Suhail, K. (2005). A study investigating mental health literacy in Pakistan. Journal of Mental Health; 14(2), 167-181.
  20. Clement S, Ibrahim S, Crichton N, Wolf M, Rowlands G. ((2009). Complex Interventions to improve the health of people with limited literacy: A systematic review. Patient Education and Counceling. 75, 340351.
  21. Kaddumukasa M1, Kakooza A2, Kaddumukasa MN1, Ddumba E3, Mugenyi L4, Sajatovic M5, Katabira E1Knowledge and Attitudes of Parkinson's Disease in Rural and Urban Mukono District, Uganda: A Cross-Sectional, Community-Based Study. Parkinsons Dis. 2015; 2015: 196150.
  22. Saleem F, Hassali MA, Shafie AA, Awad AG, Bashir S. Association between knowledge and drug adherence in patients with hypertension in Quetta, Pakistan. Trop J Pharm Res. 2011; 10:125–132.
  23. Astin JA Why patients use alternative medicine: results of a national study. JAMA. 1998 May 20; 279(19):1548-53.
  24. Siapush M. Post-modern values, dissatisfaction with conventional medicine and popularity of alternative therapies. J Social. 1998;34:58–70.
  25. Al-Rowais N, Al-Faris E, Mohammad AG, Al-Rukban M, Abdulghani HM. Traditional healers in Riyadh region: reasons and health problems for seeking their advice. A householdsurvey. J Altern Complement Med.2010 Feb;16(2):199-204.
  26. Abolfazli R, Elyasi A, Javadi MR, et al. Knowledge and attitude assessment of Iranian multiple sclerosis patients receiving interferon beta. Iranian Journal of Neurology. 2014;13(3):160-167.
   

[Mona G Amer, Wejdan A AlZahrani, Asma’a A AlZahrani, Fatimah A Altalhi, Seham S Alrubaie, Rawan A Alsini, Sara H AlZahrani and Samaher H Altowairqi. (2016); ASSESSMENT OF MULTIPLE SCLEROSIS AWARENESS: KNOWLEDGE AND ATTITUDE AMONG SAUDI POPULATION IN TAIF CITY, KSA. Int. J. of Adv. Res. 4 (Dec). 1758-1766] (ISSN 2320-5407). www.journalijar.com

Mona Gomah Amer
Associate prof. of Histology and Cell Biology

DOI:

Article DOI: 10.21474/IJAR01/2578      
DOI URL: http://dx.doi.org/10.21474/IJAR01/2578

Download Full Paper

Download PDF No. of Downloads: 193 | No. of Views: 605